Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 27, 2009
The role of selective angiographic embolization of the musculo-skeletal system in haemophiliaE C Rodriguez-Merchan, V Jimenez-Yuste
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 13, 2009
Orthopaedic surgery in haemophilia patients with inhibitors as the last resortE C Rodriguez-Merchan, M Quintana, V Jimenez-Yuste
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 16, 2002
The use of haemostatic drugs in haemophilia: desmopressin and antifibrinolytic agentsA Villar, V Jimenez-Yuste, M Quintana, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 4, 2011
What patient, joint and isotope characteristics influence the response to radiosynovectomy in patients with haemophilia?H de la Corte-Rodriguez, E C Rodriguez-Merchan, V Jimenez-Yuste
Journal of Thrombosis and Haemostasis : JTH|March 1, 2011
Radiosynovectomy in hemophilia: quantification of its effectiveness through the assessment of 10 articular parametersH De la Corte-Rodriguez, E C Rodriguez-Merchan, V Jimenez-Yuste
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 21, 2007
Orthopaedic surgery for inhibitor patients: a series of 27 procedures (25 patients)E C Rodriguez-Merchan, M Quintana, V Jimenez-Yuste, et al.
Thrombosis Research|February 11, 2014
Is radiosynovectomy (RS) effective for joints damaged by haemophilia with articular degeneration in simple radiography (ADSR)?E C Rodriguez-Merchan, H De La Corte-Rodriguez, V Jimenez-Yuste
Thrombosis Research|September 22, 2014
Radiosynovectomy in haemophilia: long-term results of 500 procedures performed in a 38-year periodE C Rodriguez-Merchan, H De la Corte-Rodriguez, V Jimenez-Yuste
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 16, 2008
Clinical efficacy in bleeding and surgery in von Willebrand patients treated with Fanhdi a highly purified, doubly inactivated FVIII/VWF concentrateF Hernandez-Navarro, M Quintana, V Jimenez-Yuste, et al.
Pageof 3